cholestyramine resin has been researched along with Stroke in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, R; Liang, J; Ren, Y; Wang, H; Wu, Q; Xie, J; Yin, J; Zhang, M; Zhu, J | 1 |
| Cho, T; Maljaars, J; Ortega-Gutierrez, S; Shaban, A | 1 |
| Bouzamondo, A; Corvol, JC; Hulot, JS; Lechat, P; Sanchez, P; Sirol, M | 1 |
| Birbeck, GL; Jacobs, BS; Kothari, RU; Maddox, K; Mullard, AJ; Reeves, MJ; Stoeckle-Roberts, S; Wehner, S | 1 |
| Agrawal, R; Arntz, HR; Fischer, F; Schnitzer, L; Schultheiss, HP; Stern, R; Wunderlich, W | 1 |
1 review(s) available for cholestyramine resin and Stroke
| Article | Year |
|---|---|
Differential effects of lipid-lowering therapies on stroke prevention: a meta-analysis of randomized trials.
Topics: Anticholesteremic Agents; Atorvastatin; Cholestyramine Resin; Clofibrate; Colestipol; Gemfibrozil; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lovastatin; Myocardial Infarction; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Regression Analysis; Risk Assessment; Risk Factors; Simvastatin; Stroke; Treatment Failure; Treatment Outcome | 2003 |
1 trial(s) available for cholestyramine resin and Stroke
| Article | Year |
|---|---|
Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study).
Topics: Adult; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Chemoprevention; Chi-Square Distribution; Cholesterol, LDL; Cholestyramine Resin; Confidence Intervals; Coronary Angiography; Coronary Artery Disease; Coronary Disease; Coronary Vessels; Drug Combinations; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Niacin; Odds Ratio; Peripheral Vascular Diseases; Pravastatin; Regression Analysis; Statistics, Nonparametric; Stroke; Survival Rate; Treatment Outcome | 2000 |
3 other study(ies) available for cholestyramine resin and Stroke
| Article | Year |
|---|---|
Cholestyramine resin administration alleviated cerebral ischemic injury in obese mice by improving gut dysbiosis and modulating the bile acid profile.
Topics: Animals; Bile Acids and Salts; Brain Injuries; Cholestyramine Resin; Chromatography, Liquid; Dysbiosis; Mice; Mice, Obese; Neuroprotective Agents; Obesity; Stroke; Tandem Mass Spectrometry | 2023 |
Q Fever, CNS Vasculitis, and Stroke: A Case Report.
Topics: Adult; Anti-Bacterial Agents; Arthritis, Rheumatoid; Cholestyramine Resin; Humans; Leflunomide; Male; Q Fever; Stroke; Vasculitis, Central Nervous System | 2020 |
Lipid testing and lipid-lowering therapy in hospitalized ischemic stroke and transient ischemic attack patients: results from a statewide stroke registry.
Topics: Aged; Anticoagulants; Cholestyramine Resin; Clofibric Acid; Female; Hospital Records; Hospitalization; Hospitals; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemia; Ischemic Attack, Transient; Lipids; Male; Middle Aged; Models, Statistical; Niacin; Registries; Risk Factors; Stroke | 2006 |